- 产品描述
- 产品组分
- 文件资源
- 营销中心
- 注意事项
- FAQ
- 文献追踪
-
环氧化酶2(COX-2)是一种双功能酶,具有COX和过氧化物酶的活性,催化前列腺素、血栓素和前列环素生物合成的第一步。COX-2的表达被各种刺激物诱导,包括抗坏血酸酯、LPS和细胞因子,并负责急性炎症条件下PGs的生物合成。3因此,COX-2一直是非甾体抗炎药(NSAID)开发的关注焦点。IVDSHOW的重组人环氧合酶-2含有一个N端六组氨酸标签,并在第580位用丙氨酸代替天冬酰胺(COX-2N580A),以防止第580位的糖基化,减少细胞中的酶降解。
Synonyms
- Cyclooxygenase 2
- Prostaglandin H Synthase 2
Purity
≥75% (estimated by SDS-PAGE)
Source
Active recombinant N-terminal His-tagged COX-2N580A mutant purified from insect cells
Amino Acids
20-604
MW
67.9 kDa
Formulation
80 mM Tris, pH 8.0, with 0.3 mM DDC, 0.01% Tween 20, and 10% glycerol
Specific Activity
>8,000 U/mg
UniProt Accession №
P35354
关键词:- 重组人环氧合酶-2
-
产品组分
内容 型号
规格 储存温度
重组人环氧合酶-2
60122 5Kunit -20°C 操作手册
1 1 常温
-
注意事项
保存建议 厂家推荐蓝冰运输。当您收到产品后,按照说明书建议保存于-20°C。 -
FAQ
-
1. Nugteren, D.H., and Hazelhof, E. Isolation and properties of intermediates in prostaglandin biosynthesis. Biochim. Biophys. Acta 326(3), 448-461 (1973).
2. Hamberg, M., and Samuelsson, B. Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis. Proc. Natl. Acad. Sci. USA 70(3), 899-903 (1973).
3. Blobaum, A.L., and Marnett, L.J. Structural and functional basis of cyclooxygenase inhibition. J. Med. Chem. 50(7), 1425-1441 (2007).
4. Sevigny, M.B., Li, C.-
F., Alas, M., et al. Glycosylation regulates turnover of cyclooxygenase- 2. FEBS Lett. 580(28-29), 6533-6536 (2006). Product Citations
Zhao-
Yong, Y., Zhi- Fei, Z., Xiao- Bo, H., et al. Study on the effect of amicoumacin B on up- regulating bmp- 2 transcription and expression in MG63 cells. Chin. J. Antibiot. 33(4), 203-205 (2008). Beeghly-
Fadiel, A., Wilson, A.J., Keene, S., et al. Differential cyclooxygenase expression levels and survival associations in type I and type II ovarian tumors. J. Ovarian Res. 11(17), (2018). Gouveia-
Figueira, S., Karlsson, J., Deplano, A., et al. Characterisation of (R)- 2- (2- fluorobiphenyl- 4- yl)- N- (3- methylpyridin- 2- yl)propanamide as a dual fatty acid amide hydrolase: Cyclooxygenase inhibitor. PLoS One 10(9), e0139212 (2015). Karlsson, J., and Fowler, C.J. Inhibition of endocannabinoid metabolism by the metabolites of ibuprofen and flurbiprofen. PLoS One 9(7), e103589 (2014).
Hoobler, E.K., Warrilow, A.G., Perry, S.C., et al. Discovery of a novel dual fungal CYP51/human 5-
lipoxygenase inhibitor: implications for anti- fungal therapy. PLoS One 8(6), e65928 (2013).
猜你喜欢
在线留言
如果您对我们的产品感兴趣,请留下您的信息,我们将尽快与您联系,谢谢!
艾维缔官网
艾德官网
B站IVDSHOW
抖音军哥聊表观
视频号艾维缔
小红书艾维缔
快手表观盒子
表观遗传学
联系我们

